SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Centocor ( CNTO )
CNTO 0.000010000.0%Jan 29 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Maxer who wrote (725)6/26/1998 12:02:00 PM
From: FNS  Read Replies (1) of 965
 
Maxer: re: << Seems like CNTO moves fast when it moves. >> AGREED!

Where are we going??? No answer, just guesses: CNTO in short term down leg with top at 39; couldn't get through so sold off yesterday ... support at 34, which I hope is not tested soon!

Avakine FDA approval is required to lift the stock plus a decent earnings report in July...but IMNX priority review of their arthritis drug is negative for CNTO! We're late out of the box! - not their yet but hopefully Avakine will be approved and Retavase proves creative to CNTO. Reopro competition is another issue. I think you'll see 45 but it may be 6 months downstream...but hopefully 55 by this time next year.

We really should hear from Bruce! Bruce, speak!

ciao,
FNS

PS: If Avakine doesn't come through (God forbid!) I'm out of CNTO and moving to ATHM! and maybe the oil drillers! (Can't take another Septic Shock!)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext